Reducible Drug Pyrazinamide as a Powerful Ligand to Assist Copper (II)‐Catalyzed N‐Arylation
Applied Organometallic Chemistry · 2025-03 · 39 (3)
DOI: 10.1002/aoc.7874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Organometallic Chemistry, online erschienen am 05.11.2024. Verfasst von Mengliang Chai und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Herein, pyrazinamide (L1) was used as a powerful ligand to promote a CuSO 4 ‐catalyzed reaction between aryl halides and imidazole (HID) under mild conditions, generating various N‐arylation products in good to excellent yields. The findings indicate that CuSO 4 was reduced and coordinated with L1 to form [Cu I L1], which activated ArX to produce [ArCu I L1X] through oxidative addition. This intermediate subsequently underwent reductive elimination to form N‐arylation products, with [ArCuILID] being generated from a reaction between [ArCuIL1X] and HID. This method was successfully extended to the synthesis of 2‐phenylindole and pyrrolo[1,2‐a]quinoxaline under mild conditions. The method significantly enhances the efficiency and cost effectiveness of C‐N coupling reaction.
Zitieren
APA
Chai, M., Wang, S., & Wu, F. (2025). Reducible Drug Pyrazinamide as a Powerful Ligand to Assist Copper (II)‐Catalyzed N‐Arylation. Applied Organometallic Chemistry, 39(3). https://doi.org/10.1002/aoc.7874
Vancouver
Chai M, Wang S, Wu F. Reducible Drug Pyrazinamide as a Powerful Ligand to Assist Copper (II)‐Catalyzed N‐Arylation. Applied Organometallic Chemistry. 2025;39(3). doi:10.1002/aoc.7874
BibTeX
@article{Chai2025,
author = {Chai, Mengliang and Wang, Sha and Wu, Fengtian},
title = {Reducible Drug Pyrazinamide as a Powerful Ligand to Assist Copper (II)‐Catalyzed N‐Arylation},
journal = {Applied Organometallic Chemistry},
year = {2025},
volume = {39},
number = {3},
doi = {10.1002/aoc.7874}
}
EUVIMED